Diazoxide Toxicity in Congenital Hyperinsulinism: A Seldom-Considered Rare Side Effect
Diazoxide is the sole approved drug for congenital hyperinsulinism; however, diuretic administration and vigilant monitoring are crucial to prevent and promptly identify potentially life-threatening adverse effects. This report aims to highlight a seldom considered rare side effect of diazoxide.